Rigel Pharmaceuticals Inc (RIGL)

Income Before Tax

$23.59M

Quarterly · Period ending: · USD

RIGL logo

RIGL Income Before Tax

Latest reported$23.59M
RIGL Quarterly Pre-Tax Income ($0.00 → $23.59M)
High-resolution chart · PNG

RIGL income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
23,585,000
11,657,000
22,714,000
27,620,000
59,982,000
11,511,000
15,222,000
12,421,000
-1,030,000
-8,247,000
737,000
-5,692,000
-6,600,000
-13,536,000
1,401,000
-19,037,000
-13,492,000
-27,445,000
-22,701,000
-21,088,000
-14,791,000
41,271,000
-19,237,000
-14,174,000
-17,576,000
21,243,000
-17,200,000
-11,490,000
-20,606,000
-17,598,000
3,228,000
-23,766,000
-25,557,000
-24,385,000
-25,871,000
-17,660,000
-19,147,000
-15,314,000
-15,590,000
-22,629,000
-13,533,000
-17,464,000
-12,687,000
-6,672,000
-13,912,000
-18,193,000
-22,272,000
-20,942,000
-25,391,000
-22,303,000
-16,861,000
-23,824,000
-22,768,000
-25,574,000
-25,472,000
-25,456,000
-24,738,000
-23,174,000
-68,042,000
-17,931,000
-21,474,000
-20,781,000
-17,239,000
50,433,000
27,029,000
-22,333,000
-25,093,000
-26,651,000
-29,908,000
-29,988,000
98,982,000
-37,691,000
-34,029,000
-27,262,000
-74,272,000
-18,944,000
-19,245,000
-17,081,000
-37,637,000
-11,382,000
-2,330,000
-8,469,000
-45,256,000
-12,906,000
-12,293,000
-11,164,000
41,529,000
-16,136,000
-12,342,000
-13,051,000
-41,197,000
-11,069,000
-10,466,000
-7,800,000
-37,030,000
-10,142,000
-10,446,000
-8,372,000
-23,805,000
-6,219,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.